Abstract
BackgroundPulmonary involvement represents a major cause of death of scleroderma patients. Cyclophosphamide showed a small beneficial effect in RCTs. There is a rational for the use of tyrosine kinase inhibitors...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have